2-Methyl-3-furoic acid → 5-(2-methyl-3-furoyl)amino-3-(1-methylpiperidin-4-yl)-1H-indole
Reaktionsgleichung
[NH2:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][CH:6]=[C:5]2[CH:11]1[CH2:16][CH2:15][N:14]([CH3:17])[CH2:13][CH2:12]1.[CH3:18][C:19]1[O:20][CH:21]=[CH:22][C:23]=1[C:24](O)=[O:25]>>[CH3:18][C:19]1[O:20][CH:21]=[CH:22][C:23]=1[C:24]([NH:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][CH:6]=[C:5]2[CH:11]1[CH2:16][CH2:15][N:14]([CH3:17])[CH2:13][CH2:12]1)=[O:25]Komponenten
3
Versuchsvorschrift
Beginning with 7.0 mg (0.03 mMol) 5-amino-3-(1-methylpiperidin-4-yl)-1H-indole and 11.3 mg (0.09 mMol) 2-methyl-3-furoic acid, 0.4 mg (4%) of the title compound were recovered.
Quellen und Nachweise
- ORD-Eintrag
- ord-42cd046ee6c6425c8fe2112be7383491
- Quelldatensatz
- uspto-grants-1999_10
- Patentnummer
- US05962474
Notizen zur Reaktion
Wird geladen…